ArticlePloS one2025
Blood urea nitrogen to serum albumin ratio predicts 28-day and 90-day mortality in patients with acute pancreatitis: A retrospective cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Are BISAP and APACHE II scores still useful to identify high-risk patients in acute pancreatitis? A retrospective multicenter analysis on 450 patients.Updates in surgery · 2026Article
- Comparative analysis of four nutritional scores in predicting hospital stay duration for EICU Patients with acute pancreatitis.Frontiers in nutrition · 2026Article
- Relationship Between Blood Urea Nitrogen to Albumin Ratio and Risks of Mortality and Delirium in Pancreatitis Patients: A Retrospective Analysis of the MIMIC-IV Database.Gastroenterology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute pancreatitis is a prevalent and severe digestive disease with significant mortality. Early identification of high-risk patients is essential for improving outcomes. The ratio of blood urea nitrogen to albumin (BAR) has emerged as a potential prognostic predictor in various critical illnesses. This study explores the associations between BAR and 28-day and 90-day mortality in acute pancreatitis patients.
methodsThis retrospective cohort study enrolled patients diagnosed with acute pancreatitis from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. BAR was calculated using initial blood urea nitrogen and serum albumin. Patients were categorized into three groups according to the tertiles (T1-T3) of BAR values. Kaplan-Meier survival analysis and restricted cubic spline (RCS) curve assessed the impact of BAR on overall survival. Multivariate Cox regression analysis was used to determine association of BAR with 28-day and 90-day mortality in acute pancreatitis. The receiver operating characteristic (ROC) curve was employed to assess the predictive value of BAR for 28-day and 90-day mortality in acute pancreatitis.
resultsIn this study, 452 patients with acute pancreatitis were analyzed, with 28-day mortality rate of 11.7% and 90-day mortality rate of 13.7%. Kaplan-Meier survival analysis indicated a notable increase in mortality rates at 28 days and 90 days among patients with elevated BAR levels (Log-rank P < 0.001). Moreover, RCS curve demonstrated a linear and positive relationship between BAR levels and mortality rates at 28 days and 90 days after adjusting all covariates. Multivariate Cox regression analysis identified BAR as an independent risk factor for 28-day and 90-day mortality. Subgroup analysis confirmed a consistent correlation between elevated BAR levels and poor outcomes in acute pancreatitis patients. The area under the curve (AUC) of BAR for predicting 28-day and 90-day mortality was 0.802 and 0.798 respectively, both performing comparably to the Simplified Acute Physiology Score II (SAPS II).
conclusionHigher BAR values were significantly associated with increased 28-day and 90-day mortality in acute pancreatitis patients. Moreover, BAR may serve as a simple and effective tool for identifying higher death risk of patients with acute pancreatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.